Not applicableStudy completedNCT00088803What this trial is testingDNA Variations in the Gene in Young Patients With Wilms' TumorWho this might be right forKidney Cancer Children's Oncology Group 471
Early research (Phase 1)Study completedNCT00931931What this trial is testingHSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid TumorsWho this might be right forRhabdomyosarcomaOsteosarcomaEwing Sarcoma+6 more Timothy Cripe 18
Not applicableStudy completedNCT00080873What this trial is testingTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationWho this might be right forKidney CancerLeukemiaLymphoma+3 more Children's Oncology Group 195
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)UnknownNCT00314925What this trial is testingSafety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine FeaturesWho this might be right forCarcinoidNeuroendocrine Neotropix 60
Early research (Phase 1)Looking for participantsNCT06917885What this trial is testingCUE-102 in Recurrent GlioblastomaWho this might be right forRecurrent GlioblastomaGlioblastomaGlioma, Malignant David Reardon, MD 18
Testing effectiveness (Phase 2)UnknownNCT00025103What this trial is testingChemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the KidneyWho this might be right forKidney Cancer Children's Cancer and Leukaemia Group 75
Early research (Phase 1)Looking for participantsNCT07148050What this trial is testingImmunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T CellsWho this might be right forSolid Tumor (Excluding CNS)Liver Cell CarcinomaMalignant Rhabdoid Tumor+7 more Seattle Children's Hospital 21
Early research (Phase 1)Study completedNCT00270452What this trial is testingSafety of Peptide Vaccination for Patients With Myelodysplastic SyndromeWho this might be right forMyelodysplastic Syndrome (MDS) National Heart, Lung, and Blood Institute (NHLBI) 9
Not applicableNot Yet RecruitingNCT07605884What this trial is testingDenys-Drash Syndrome and Risk of Post-transplant Lymphoproliferative DisorderWho this might be right forDenys-Drash Syndrome Assistance Publique - Hôpitaux de Paris 108
Not applicableStudy completedNCT01550393What this trial is testingBiomarkers in Urine Samples From Patients With Wilms TumorWho this might be right forKidney Cancer Children's Oncology Group 100
Not applicableLooking for participantsNCT06674811What this trial is testingBiomarkers of Resiliency In Childhood Cancer SurgeryWho this might be right forPediatric CancerNeuroblastomaSarcoma+10 more Mayo Clinic 40
Early research (Phase 1)Study completedNCT01758328What this trial is testingDose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00488592What this trial is testingPeptide Vaccinations to Treat Patients With Low-Risk Myeloid CancersWho this might be right forMyelodysplastic Syndrome (MDS)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML) National Heart, Lung, and Blood Institute (NHLBI) 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620What this trial is testingTargeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more National Cancer Institute (NCI) 1,377
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Not applicableUnknownNCT04814758What this trial is testingDWI in the Diagnosis of Histological Types of Nephroblastoma in ChildrenWho this might be right forNephroblastoma (Wilms Tumour) Federal Research Institute of Pediatric Hematology, Oncology and Immunology 230
Testing effectiveness (Phase 2)UnknownNCT06172634What this trial is testingA Single-center Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow-derived DCs(CellgramDC-WT1) and Immune Checkpoint Inhibitors in Patients With Metastatic Pancreatic Cancer Who Have Failed First-line or More Standard ChemotherapyWho this might be right forPancreas Cancer Soonchunhyang University Hospital 10
Testing effectiveness (Phase 2)Study completedNCT00001509What this trial is testingA Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' TumorWho this might be right forNephroblastomaNeuroblastoma National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)UnknownNCT04284228What this trial is testingAntigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCTWho this might be right forAcute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS) NexImmune Inc. 22